<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Ongoing empiric antimicrobial therapy for children with fever and chemotherapy-induced neutropenia who remain clinically stable and have no documented infection</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Ongoing empiric antimicrobial therapy for children with fever and chemotherapy-induced neutropenia who remain clinically stable and have no documented infection</h1>
<div class="graphic"><div class="figure"><div class="ttl">Ongoing empiric antimicrobial therapy for children with fever and chemotherapy-induced neutropenia who remain clinically stable and have no documented infection</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">This algorithm is intended for use in conjunction with UpToDate content on fever in children with chemotherapy-induced neutropenia. Refer to UpToDate content for details of pretreatment evaluation, risk stratification, initial choice of empiric antimicrobial therapy, reevaluation during treatment, modifications to empiric antimicrobial therapy for children with clinical worsening or instability or children with clinically or microbiologically documented infection, switching from IV to oral therapy, and choice of empiric antifungal therapy.</div><div class="graphic_footnotes">ANC: absolute neutrophil count; US: ultrasonography; CT: computed tomography; IV intravenous.<br/>* For low-risk patients who have received IV antibiotics for ≥72 hours, have been afebrile for ≥24 hours, and have no documented infection, some experts permit discontinuation of antibiotics regardless of marrow recovery if follow-up is ensured.<br/>¶ If agents with additional activity against gram-positive (eg, vancomycin, clindamycin, linezolid) or gram-negative (eg, aminoglycosides) pathogens were added to initial empiric therapy, discontinue them after 48 hours if initial cultures remain negative.<br/>Δ For children with clinical worsening or instability, reevaluate diagnosis and treatment. Refer to the UpToDate topic on fever in children with chemotherapy-induced neutropenia.<br/><font class="lozenge">◊</font> Factors that influence the choice of empiric antifungal therapy include antifungal prophylaxis and renal or hepatic dysfunction. For empiric antifungal therapy in children who have been receiving antifungal prophylaxis, we choose an antifungal agent from a different class than their prophylactic therapy. We generally prefer lipid formulations of amphotericin for children with renal dysfunction and anidulafungin for children with hepatic and/or renal dysfunction.</div><div class="graphic_reference">References: 

<ol>
<li>Lehrnbecher T, Robinson P, Fisher B, et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol 2017; 35:2082.</li>
<li>Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011; 52:e56.</li></ol></div><div id="graphicVersion">Graphic 120294 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
